<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">De Bruyne, Bernard</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">FAME 2: FFR—Guided PCI Reduces Urgent Revascularization</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-30</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents updated trial data that demonstrated that fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) reduces cardiovascular events when compared to medical therapy in patients with stable coronary artery disease (CAD). The Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment (OMT) Versus OMT trial [FAME 2; De Bruyne B et al. N Engl J Med. 2014] was undertaken to determine if FFR-guided PCI improves outcomes in patients with stable CAD.</style></abstract><number><style face="normal" font="default" size="100%">27</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>